Contact Information: CONTACT INFORMATION: David Richardson 919-433-0216
Pharmaceutical Competitive Intelligence Groups More Globally Structured
| Quelle: Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwire - May 22, 2008) - Pharmaceutical competitive
intelligence groups are becoming more globally focused, rather than being
contained within each region in which a company is active, according to a
new report by Cutting Edge Information. The report, "Pharmaceutical
Competitive Intelligence: Expanding the Role and Reach of CI," examines the
evolution of the CI function and reveals that companies are pursuing this
structure for many reasons (www.pharmacompetitiveintelligence.com).
Top pharmaceutical companies are finding a global CI group to be more
efficient, as poor or nonexistent communication among therapeutically
aligned CI groups means expensive work is needlessly duplicated. A single
global group is more likely to share best practices, resources, and
information, even if CI staff is therapeutically aligned within the global
group. Competitive intelligence groups that are globally aligned are also
more likely to use standardized practices, which ensure that all
therapeutic areas within the company receive the same high-quality
research.
A global alignment also allows the CI group to play a more strategic role
in marketing decisions for brands. "Companies increasingly depend on
global CI groups to go beyond compiling data and instead provide
forward-thinking strategic analysis. Marketing strategies are also
considered globally in the case of many top brands, and solid market
analysis is required for the development of these strategies," said David
Richardson, lead author of the report. "A globally aligned CI department
is best positioned to deliver this analysis."
The 116-page report examines CI team structures, phase-by-phase spending
and staffing, and strategies for improvement. Compiled from surveys and
interviews with executives at leading companies, the report enables CI
teams to achieve success.
A summary of the report is available for download here:
http://www.cuttingedgeinfo.com/pharmacompetitiveintelligence/PH110_Download.asp#body